Quantcast This Is Your State - This Is Your State On Drugs
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

This Is Your State - This Is Your State On Drugs

Posted on 09/13/2007 06:25:45 | Link | Post Comment
by Mark S. Senak
Eye On FDA



I'm a bit late on this update, which came out late last month, but the National Conference of State Legislatures has released another overview of what states are doing in legislation so far this year in healthcare. Here are a few of the highlights.

One of the most active areas of activity involved marketing practices and advertising. The NCSL reports that during 2007 there were 27 states with proposed legislation that would require drug manufacturers to disclose certain information, would regulate DTC or would prohibit the sale of prescription information. Legislation along these lines was passed in Maine, Texas and Vermont, with a host of others considering proposed legislation.

Proposed legislation aside, laws and resolutions have been passed in half of the states. This includes action in Louisiana, Mississippi, Rhode Island, Tennessee and Utah to provide access to brand name pharmaceutical products. Similar legislation is proposed in Florida, Georgia, Idaho, Kentucky, New York, Pennsylvania, Washington and Wisconsin. Some of these include such matters that you would have thought were already taken care of - such as the passage of a law by Arkansas that prohibits online sales of drugs without the patient consulting with a prescribing practitioner. Other more intersting efforts are represented by Arizona which passed legislation allowing access to prescription drugs in times of emergency.

The regulation of drug importation or reimportation was taken up and addressed in Mississippi, with other legislation proposed in Hawaii, Kentucky, Massachusetts, New York, Oklahoma and Tennessee.

The link above also shows you activity by state, as well as by area of interest. The range is quite startling, with North Carolina having only 1 bill proposed and New York with a whopping 73 bills for consideration.




Eye On FDA is a regular contributor to BioHealth Investor
___________
Stock Quote or
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Tue Jul 22, 2008 09:23AM
Hedge funds have made billions this year shorting the banks, [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.